Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein

Caroline Lambert (1, 2) , Mathilde Couteaudier (1) , Julie Gouzil (1) , Léa Richard (1) , Thomas Montange (1) , Edouard Betsem (1) , Rejane Rua (1) , Joelle Tobaly-Tapiero (3) , Dirk Lindemann (4) , Richard Njouom (5) , Antoine Gessain (1) , Augustin Mouinga-Ondemé (6) , Florence Buseyne (1)

1 EPVO (UMR_3569 / U-Pasteur_3) - Epidémiologie et Physiopathologie des Virus Oncogènes
2 Cellule Pasteur
3 Pathologie cellulaire : aspects moléculaires et viraux / Pathologie et Virologie Moléculaire
4 Institute of Virology [Dresden]
5 Centre Pasteur du Cameroun
6 CIRMF - Centre International de Recherches Médicales de Franceville

Human diseases of zoonotic origin are a major public health problem. Simian foamy viruses (SFVs) are complex retroviruses which are currently spilling over to humans. Replication-competent SFVs persist over the lifetime of their human hosts, without spreading to secondary hosts, suggesting the presence of efficient immune control. Accordingly, we aimed to perform an in-depth characterization of neutralizing antibodies raised by humans infected with a zoonotic SFV. We quantified the neutralizing capacity of plasma samples from 58 SFV-infected hunters against primary zoonotic gorilla and chimpanzee SFV strains, and laboratory-adapted chimpanzee SFV. The genotype of the strain infecting each hunter was identified by direct sequencing of the env gene amplified from the buffy coat with genotype-specific primers. Foamy virus vector particles (FVV) enveloped by wild-type and chimeric gorilla SFV were used to map the envelope region targeted by antibodies. Here, we showed high titers of neutralizing antibodies in the plasma of most SFV-infected individuals. Neutralizing antibodies target the dimorphic portion of the envelope protein surface domain. Epitopes recognized by neutralizing antibodies have been conserved during the cospeciation of SFV with their nonhuman primate host. Greater neutralization breadth in plasma samples of SFV-infected humans was statistically associated with smaller SFV-related hematological changes. The neutralization patterns provide evidence for persistent expression of viral proteins and a high prevalence of coinfection. In conclusion, neutralizing antibodies raised against zoonotic SFV target immunodominant and conserved epitopes located in the receptor binding domain. These properties support their potential role in restricting the spread of SFV in the human population.

Mots clés: Gorillas; Antibodies; Chimpanzees; Blood plasma; Zoonoses; Co-infections; Viral replication; Polymerase chain reaction

Domaines: Immunité adaptative; Virologie; Maladies émergentes; Maladies infectieuses; Pédiatrie

Caroline Lambert, Mathilde Couteaudier, Julie Gouzil, Léa Richard, Thomas Montange, et al.. Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein. PLoS Pathogens, 2018, 14 (10), pp.e1007293. ⟨10.1371/journal.ppat.1007293⟩. ⟨pasteur-02313509⟩